Cervical cancer prevention

Tomas Nuño, Jessamyn Bowling, Francisco A Garcia

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cervical cancer is the most common gynecologic malignancy worldwide, accounting for about 530,000 new cases each year. Most of these cases (90 %) occur in the developing world where it is the second most common malignancy in women after breast cancer. By contrast, in the United States of America (USA) cervical cancer has decreased dramatically since the introduction of cytologic screening (Pap smear), and is now a relatively infrequent neoplasm, especially among well-screened majority populations with access to health-care services. In the USA, an individual woman’s lifetime risk of developing cervical cancer is estimated to be 1 in 147. In 2012, it is estimated that there were approximately 12,170 new cases of cervical cancer and 4,220 deaths in the USA.

Original languageEnglish (US)
Title of host publicationFundamentals of Cancer Prevention, Third Edition
PublisherSpringer Berlin Heidelberg
Pages533-556
Number of pages24
ISBN (Print)9783642389832, 9783642389825
DOIs
StatePublished - Jan 1 2014

Fingerprint

Uterine Cervical Neoplasms
Papanicolaou Test
Neoplasms
Health Services Accessibility
Health Services
Breast Neoplasms
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nuño, T., Bowling, J., & Garcia, F. A. (2014). Cervical cancer prevention. In Fundamentals of Cancer Prevention, Third Edition (pp. 533-556). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-38983-2_17

Cervical cancer prevention. / Nuño, Tomas; Bowling, Jessamyn; Garcia, Francisco A.

Fundamentals of Cancer Prevention, Third Edition. Springer Berlin Heidelberg, 2014. p. 533-556.

Research output: Chapter in Book/Report/Conference proceedingChapter

Nuño, T, Bowling, J & Garcia, FA 2014, Cervical cancer prevention. in Fundamentals of Cancer Prevention, Third Edition. Springer Berlin Heidelberg, pp. 533-556. https://doi.org/10.1007/978-3-642-38983-2_17
Nuño T, Bowling J, Garcia FA. Cervical cancer prevention. In Fundamentals of Cancer Prevention, Third Edition. Springer Berlin Heidelberg. 2014. p. 533-556 https://doi.org/10.1007/978-3-642-38983-2_17
Nuño, Tomas ; Bowling, Jessamyn ; Garcia, Francisco A. / Cervical cancer prevention. Fundamentals of Cancer Prevention, Third Edition. Springer Berlin Heidelberg, 2014. pp. 533-556
@inbook{b0c14633eb564a2cac4c4c4e69a87cd8,
title = "Cervical cancer prevention",
abstract = "Cervical cancer is the most common gynecologic malignancy worldwide, accounting for about 530,000 new cases each year. Most of these cases (90 {\%}) occur in the developing world where it is the second most common malignancy in women after breast cancer. By contrast, in the United States of America (USA) cervical cancer has decreased dramatically since the introduction of cytologic screening (Pap smear), and is now a relatively infrequent neoplasm, especially among well-screened majority populations with access to health-care services. In the USA, an individual woman’s lifetime risk of developing cervical cancer is estimated to be 1 in 147. In 2012, it is estimated that there were approximately 12,170 new cases of cervical cancer and 4,220 deaths in the USA.",
author = "Tomas Nu{\~n}o and Jessamyn Bowling and Garcia, {Francisco A}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-3-642-38983-2_17",
language = "English (US)",
isbn = "9783642389832",
pages = "533--556",
booktitle = "Fundamentals of Cancer Prevention, Third Edition",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Cervical cancer prevention

AU - Nuño, Tomas

AU - Bowling, Jessamyn

AU - Garcia, Francisco A

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Cervical cancer is the most common gynecologic malignancy worldwide, accounting for about 530,000 new cases each year. Most of these cases (90 %) occur in the developing world where it is the second most common malignancy in women after breast cancer. By contrast, in the United States of America (USA) cervical cancer has decreased dramatically since the introduction of cytologic screening (Pap smear), and is now a relatively infrequent neoplasm, especially among well-screened majority populations with access to health-care services. In the USA, an individual woman’s lifetime risk of developing cervical cancer is estimated to be 1 in 147. In 2012, it is estimated that there were approximately 12,170 new cases of cervical cancer and 4,220 deaths in the USA.

AB - Cervical cancer is the most common gynecologic malignancy worldwide, accounting for about 530,000 new cases each year. Most of these cases (90 %) occur in the developing world where it is the second most common malignancy in women after breast cancer. By contrast, in the United States of America (USA) cervical cancer has decreased dramatically since the introduction of cytologic screening (Pap smear), and is now a relatively infrequent neoplasm, especially among well-screened majority populations with access to health-care services. In the USA, an individual woman’s lifetime risk of developing cervical cancer is estimated to be 1 in 147. In 2012, it is estimated that there were approximately 12,170 new cases of cervical cancer and 4,220 deaths in the USA.

UR - http://www.scopus.com/inward/record.url?scp=84955736729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955736729&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-38983-2_17

DO - 10.1007/978-3-642-38983-2_17

M3 - Chapter

AN - SCOPUS:84955736729

SN - 9783642389832

SN - 9783642389825

SP - 533

EP - 556

BT - Fundamentals of Cancer Prevention, Third Edition

PB - Springer Berlin Heidelberg

ER -